We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EVGN market cap is 204.25M. The company's latest EPS is USD -0.5027 and P/E is -8.55.
| Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 312k | 466k | 641k | 654k | 3.77M |
| Operating Income | -8.01M | -7.1M | -6.8M | -7.9M | -4.18M |
| Net Income | -8.82M | -6.53M | -6.27M | -7.02M | -3.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 753k | 1.04M | 930k | 5.18M | 5.64M |
| Operating Income | -21.17M | -24.81M | -30.95M | -26.94M | -26.51M |
| Net Income | -18.11M | -23.37M | -27.79M | -26.64M | -23.88M |
| Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 56.66M | 59.39M | 49.48M | 53.34M | 57.75M |
| Total Liabilities | 11.27M | 21.09M | 20.98M | 22.23M | 21.88M |
| Total Equity | 45.4M | 38.3M | 28.5M | 31.11M | 35.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 71.36M | 71.92M | 76.3M | 56.13M | 51.1M |
| Total Liabilities | 11.15M | 15.03M | 12.88M | 21.34M | 22.42M |
| Total Equity | 60.22M | 56.88M | 63.42M | 34.79M | 28.69M |
| Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.66M | -7.06M | -6.24M | -5.09M | -4.32M |
| Investing | 1.76M | -22k | 304k | -7.9M | 3.64M |
| Financing | -369k | 10.17M | 53k | 10.45M | 7.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.67M | -19.51M | -24.72M | -23.68M | -21.58M |
| Investing | 37.14M | 9.42M | -20.57M | 13.27M | -4.54M |
| Financing | 9.31M | 20.37M | 30.28M | 9.34M | 18.15M |
| Market Cap | 204.25M |
| Price to Earnings Ratio | -8.55 |
| Price to Sales Ratio | 36.23 |
| Price to Cash Ratio | 9.83 |
| Price to Book Ratio | 7.12 |
| Dividend Yield | - |
| Shares Outstanding | 47.5M |
| Average Volume (1 week) | 29.77k |
| Average Volume (1 Month) | 174.25k |
| 52 Week Change | -55.21% |
| 52 Week High | 10.40 |
| 52 Week Low | 4.20 |
| Spread (Intraday) | 0.44 (9.44%) |
| Company Name | Evogene Ltd |
| Address |
13 gad feinstein street, park rehovot rehovot, center 7414002 |
| Website | https://www.evogene.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
